Nature's Miracle Holding Financials
This page shows Nature's Miracle Holding (NMHIW) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 4 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
External financing is carrying a business whose sales base has collapsed faster than costs and obligations are shrinking.
Between FY2024 and FY2025, revenue fell from$9.3M to$1.7M while total assets rose from$11.3M to$20.4M . That unusual combination points to a company getting larger on paper but smaller in operating throughput, with liabilities climbing to$31.7M and financing inflows of$4.5M used to support a much thinner revenue base.
The tightest constraint is near-term liquidity: FY2025 ended with just
Losses are not only a revenue problem but a cost-structure problem: FY2025 gross profit was
Financial Health Signals
Scored against emerging companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Nature's Miracle Holding's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Nature's Miracle Holding passes 4 of 9 financial strength tests. 2 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.
For every $1 of reported earnings, Nature's Miracle Holding generates $0.33 in operating cash flow (-$4.0M OCF vs -$12.0M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.
Nature's Miracle Holding earns $-11.4 in operating income for every $1 of interest expense (-$7.2M vs $628K). This narrow margin raises concern about the company's ability to service its debt if operating income declines.
Key Financial Metrics
Earnings & Revenue
Nature's Miracle Holding generated $1.7M in revenue in fiscal year 2025. This represents a decrease of 81.2% from the prior year.
Nature's Miracle Holding's EBITDA was -$6.8M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 32.8% from the prior year.
Nature's Miracle Holding reported -$12.0M in net income in fiscal year 2025. This represents an increase of 12.2% from the prior year.
Nature's Miracle Holding earned $-0.81 per diluted share (EPS) in fiscal year 2025. This represents an increase of 93.2% from the prior year.
Cash & Balance Sheet
Nature's Miracle Holding held $98K in cash against $5.4M in long-term debt as of fiscal year 2025.
Nature's Miracle Holding had 113M shares outstanding in fiscal year 2025. This represents an increase of 4515.0% from the prior year.
Margins & Returns
Nature's Miracle Holding's gross margin was -25.9% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 4.4 percentage points from the prior year.
Nature's Miracle Holding's operating margin was -410.5% in fiscal year 2025, reflecting core business profitability. This is down 298.8 percentage points from the prior year.
Nature's Miracle Holding's net profit margin was -688.0% in fiscal year 2025, showing the share of revenue converted to profit. This is down 540.5 percentage points from the prior year.
Capital Allocation
NMHIW Income Statement
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $42K-47.4% | $79K+9.4% | $72K-85.0% | $484K-56.3% | $1.1M+84.7% | $599K-80.4% | $3.1M-10.3% | $3.4M |
| Cost of Revenue | $39K-94.7% | $735K+921.4% | $72K-84.2% | $455K-51.1% | $932K-78.8% | $4.4M+55.7% | $2.8M-4.3% | $3.0M |
| Gross Profit | $3K+100.4% | -$656K-154025.4% | $426-98.5% | $29K-83.5% | $175K+104.6% | -$3.8M-1764.9% | $228K-49.6% | $452K |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | $1.1M-18.6% | $1.3M+11.1% | $1.2M+17.5% | $1.0M-21.9% | $1.3M-30.9% | $1.9M-13.2% | $2.2M+26.9% | $1.7M |
| Operating Income | -$1.1M+69.0% | -$3.5M-163.4% | -$1.3M-15.5% | -$1.2M+0.7% | -$1.2M+80.9% | -$6.1M-203.9% | -$2.0M-55.3% | -$1.3M |
| Interest Expense | $781K+153.1% | -$1.5M-347.0% | $595K-1.8% | $606K-32.4% | $897K+167.4% | -$1.3M-280.2% | $738K+51.8% | $487K |
| Income Tax | N/A | N/A | N/A | N/A | $2K | N/A | N/A | $800 |
| Net Income | $2.8M+147.5% | -$6.0M-171.4% | -$2.2M-24.6% | -$1.8M+12.3% | -$2.0M+70.4% | -$6.8M-148.3% | -$2.8M-55.5% | -$1.8M |
| EPS (Diluted) | $0.01 | N/A | $-0.20+31.0% | $-0.29+32.6% | $-0.43 | N/A | $-2.73-35.8% | $-2.01 |
NMHIW Balance Sheet
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $21.5M+5.5% | $20.4M-11.3% | $23.0M+154.0% | $9.1M-7.8% | $9.8M-13.1% | $11.3M-18.6% | $13.9M+4.8% | $13.3M |
| Current Assets | $1.3M+31.7% | $956K-70.3% | $3.2M+13.2% | $2.8M-18.7% | $3.5M-32.4% | $5.2M-35.4% | $8.0M+9.2% | $7.3M |
| Cash & Equivalents | $46K-53.2% | $98K+59.0% | $61K+546.1% | $10K-46.1% | $18K-95.8% | $420K+947.3% | $40K+31.4% | $31K |
| Inventory | N/A | N/A | $639K-9.0% | $703K-18.9% | $867K-51.2% | $1.8M-46.6% | $3.3M-20.0% | $4.2M |
| Accounts Receivable | $146K-4.3% | $153K-87.5% | $1.2M-15.4% | $1.4M-17.2% | $1.7M-4.7% | $1.8M-23.0% | $2.4M+15.7% | $2.1M |
| Goodwill | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $29.3M-7.5% | $31.7M+0.4% | $31.6M+21.2% | $26.0M+3.1% | $25.2M-1.6% | $25.7M-0.3% | $25.7M-2.5% | $26.4M |
| Current Liabilities | $18.9M-18.8% | $23.3M+1.3% | $23.0M+12.8% | $20.4M+4.6% | $19.5M-1.5% | $19.8M+0.2% | $19.7M-3.1% | $20.4M |
| Long-Term Debt | $7.4M+37.5% | $5.4M-0.6% | $5.4M-1.5% | $5.5M-1.4% | $5.6M-1.4% | $5.7M-1.4% | $5.8M-1.3% | $5.8M |
| Total Equity | -$9.3M+27.3% | -$12.7M-36.1% | -$9.4M+44.8% | -$17.0M-10.1% | -$15.4M-7.5% | -$14.3M-19.8% | -$12.0M+9.8% | -$13.3M |
| Retained Earnings | -$34.0M+7.7% | -$36.8M-19.7% | -$30.7M-7.8% | -$28.5M-6.6% | -$26.8M-8.2% | -$24.7M-39.1% | -$17.8M-18.3% | -$15.0M |
NMHIW Cash Flow Statement
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$1.6M+26.3% | -$2.2M-143.1% | -$896K-184.7% | -$315K+47.0% | -$594K+78.5% | -$2.8M-93.5% | -$1.4M-47.4% | -$969K |
| Capital Expenditures | $1.0M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow | -$2.6M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Investing Cash Flow | -$1.0M | $0+100.0% | -$142K+66.2% | -$421K-40.3% | -$300K | $0 | $0 | $0 |
| Financing Cash Flow | $2.6M+15.2% | $2.2M+103.2% | $1.1M+49.9% | $728K+48.1% | $491K-84.4% | $3.1M+118.7% | $1.4M+105.5% | $700K |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
NMHIW Financial Ratios
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 7.0%+835.4pp | -828.4%-829.0pp | 0.6%-5.4pp | 6.0%-9.9pp | 15.8%+649.7pp | -633.9%-641.3pp | 7.5%-5.8pp | 13.3% |
| Operating Margin | -2614.7%+1815.8pp | -4430.6%-2590.8pp | -1839.7%-1601.6pp | -238.2%-133.3pp | -104.9%+907.4pp | -1012.3%-946.9pp | -65.4%-27.6pp | -37.7% |
| Net Margin | 6838.8%+14405.2pp | -7566.4%-4517.3pp | -3049.1%-2683.2pp | -365.9%-183.4pp | -182.5%+957.1pp | -1139.6%-1049.5pp | -90.1%-38.2pp | -51.9% |
| Return on Equity | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Assets | 13.2%+42.6pp | -29.3%-19.8pp | -9.6%+10.0pp | -19.6%+1.0pp | -20.5%+39.8pp | -60.4%-40.6pp | -19.8%-6.5pp | -13.3% |
| Current Ratio | 0.07+0.0 | 0.04-0.1 | 0.140.0 | 0.14-0.0 | 0.18-0.1 | 0.26-0.1 | 0.41+0.0 | 0.36 |
| Debt-to-Equity | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| FCF Margin | -6262.7% | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Note: Shareholder equity is negative (-$12.7M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Note: The current ratio is below 1.0 (0.04), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Frequently Asked Questions
What is Nature's Miracle Holding's annual revenue?
Nature's Miracle Holding (NMHIW) reported $1.7M in total revenue for fiscal year 2025. This represents a -81.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Nature's Miracle Holding's revenue growing?
Nature's Miracle Holding (NMHIW) revenue declined by 81.2% year-over-year, from $9.3M to $1.7M in fiscal year 2025.
Is Nature's Miracle Holding profitable?
No, Nature's Miracle Holding (NMHIW) reported a net income of -$12.0M in fiscal year 2025, with a net profit margin of -688.0%.
What is Nature's Miracle Holding's EBITDA?
Nature's Miracle Holding (NMHIW) had EBITDA of -$6.8M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Nature's Miracle Holding have?
As of fiscal year 2025, Nature's Miracle Holding (NMHIW) had $98K in cash and equivalents against $5.4M in long-term debt.
What is Nature's Miracle Holding's gross margin?
Nature's Miracle Holding (NMHIW) had a gross margin of -25.9% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Nature's Miracle Holding's operating margin?
Nature's Miracle Holding (NMHIW) had an operating margin of -410.5% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Nature's Miracle Holding's net profit margin?
Nature's Miracle Holding (NMHIW) had a net profit margin of -688.0% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Nature's Miracle Holding's operating cash flow?
Nature's Miracle Holding (NMHIW) generated -$4.0M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Nature's Miracle Holding's total assets?
Nature's Miracle Holding (NMHIW) had $20.4M in total assets as of fiscal year 2025, including both current and long-term assets.
What is Nature's Miracle Holding's current ratio?
Nature's Miracle Holding (NMHIW) had a current ratio of 0.04 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.
What is Nature's Miracle Holding's return on assets (ROA)?
Nature's Miracle Holding (NMHIW) had a return on assets of -58.7% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Nature's Miracle Holding's cash runway?
Based on fiscal year 2025 data, Nature's Miracle Holding (NMHIW) had $98K in cash against an annual operating cash burn of $4.0M. This gives an estimated cash runway of approximately 0 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.
Why is Nature's Miracle Holding's debt-to-equity ratio negative or not reported?
Nature's Miracle Holding (NMHIW) has negative shareholder equity of -$12.7M as of fiscal year 2025, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.
What is Nature's Miracle Holding's Piotroski F-Score?
Nature's Miracle Holding (NMHIW) has a Piotroski F-Score of 4 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Nature's Miracle Holding's earnings high quality?
Nature's Miracle Holding (NMHIW) has an earnings quality ratio of 0.33x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Nature's Miracle Holding cover its interest payments?
Nature's Miracle Holding (NMHIW) has an interest coverage ratio of -11.4x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Nature's Miracle Holding?
Nature's Miracle Holding (NMHIW) scores 4 out of 100 on our Financial Health Score, indicating weak standing within its emerging companies peer group. The score is a 0-100 composite of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.